L&G PHARMA BREAKTHROUGH UCITS ETF - USD Zu einer Liste hinzufügen
|
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| - CHF | -.--% |
|
-.--% | -.--% |
Anlageziel
Der L&G Pharma Breakthrough UCITS ETF (der "ETF") zielt darauf ab, die Wertentwicklung des Solactive Pharma Breakthrough Value Index (der "Index") abzubilden.
| Name |
Kurs
|
%
|
% 5 Tage
|
% 1. Jan.
|
Gewichtung
| |
|---|---|---|---|---|---|---|
| 297.1 USD | +3.12% | +7.92% | +35.09% | 2,55% | ||
| 270.3 SEK | -0.11% | +0.60% | +1.27% | 2,55% | ||
| 3’185 JPY | +1.27% | +0.79% | +3.07% | 2,50% | ||
| - RUB | - | - | - | 2,48% | ||
| - CAD | -.--% | - | - | 2,48% | ||
| - AUD | -.--% | - | - | 2,48% | ||
| - USD | -.--% | - | - | 2,48% | ||
| - AUD | -.--% | - | - | 2,48% | ||
| - EUR | -.--% | - | - | 2,48% | ||
| - EUR | -.--% | - | - | 2,48% | ||
| - NOK | -.--% | - | - | 2,48% | ||
| 0.214 EUR | -.--% | - | - | 2,48% | ||
| - GBX | -.--% | - | - | 2,48% | ||
| 0.3938 CAD | -17.11% | - | - | 2,48% | ||
| 21.1 CAD | -0.24% | - | - | 2,48% | ||
| 158.8 DKK | -0.19% | -7.61% | -10.37% | 2,41% | ||
| 226.5 USD | -2.26% | +0.21% | -12.49% | 2,40% | ||
| 6’295 JPY | -1.25% | -5.32% | -10.73% | 2,38% | ||
| 5’311 JPY | -1.65% | -7.95% | +37.16% | 2,37% | ||
| 1’803 DKK | +0.19% | -4.67% | -16.22% | 2,37% | ||
Mehr Börsen-Nachrichten
In Zusammenarbeit mit
Beschreibung
| ISIN Code | IE00BF0H7608 |
|---|---|
| Verwaltungsgebühren | 0.49% |
| Anlageklassen | |
| Branche | |
| Wert | |
| Währung | |
| Fondsgesellschaft | |
| Basiswert | Solactive Pharma Breakthrough Value NTR Index - USD |
Merkmale
| Gerichtsstand | |
| Replikationsmethode | |
| Replikationsmodell | |
| Erstellungsdatum |
23.01.2018
|
| Dividenden-Politik | |
| Geographischer Fokus |
Entwicklungen der ausstehenden Beträge ( 31.05.2024 )
| Volumen (EUR) | 17 M€ |
|---|---|
| Volumen 1M | 17 M€ |
| Volumen 3M | 21 M€ |
| Volumen 6M | 28 M€ |
| Volumen 12M | 56 M€ |
